Trademark Search in Canada

X4 PHARMACEUTICALS

View On IC.GC.CA

REGISTERED

on 13 Dec 2024

Last Applicant/ Owned by

X4 Pharmaceuticals, Inc.

955 Massachusetts Avenue, 4th FloorCambridge MA 02139

Serial Number

2173333 filed on 31^st Jan 2022

Registration Number

TMA1275806 registered on 13^th Dec 2024

Registration expiry Date

31^st Jan 2032

Correspondent Address

CPST INTELLECTUAL PROPERTY INC.

130 Queens Quay EastEast Tower, Suite 809Toronto,

ONTARIO

M5A0P6

X4 PHARMACEUTICALS

Trademark usage description

pharmaceutical preparations for the treatment of cancers, blood disorders, neurological disorders, namely central nervous system disorders, amyotrophi Read More

Vienna Information

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

27 . 7 . 1

Numerals presenting a special form of writingChiffres présentant un graphisme spécial

27 . 7 . 11

Numerals juxtaposed or joined to a letter or a figurative elementChiffres juxtaposés ou accolés à une lettre ou à un élément figuratif

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of cancers, blood disorders, neurological disorders, namely central nervous system disorders, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, muscular dystrophy, cerebral palsy, spina bifida, encephaly, myelopathy, migraines, ischemia, stroke, ataxia, sciatica, muscular sclerosis, neuropathic pain, central nervous system infections, neuromuscular disorders, neuroinflammatory disease, neural degeneration, brain injury, spinal cord injury and seizure disorders, genetic disorders, primary immune disorders.

Classification kind code

Class [042]
Research and development in the pharmaceutical field; scientific research in the fields of pharmacology, pharmaceuticals, biochemistry and pharmacovigilance; scientific research for medical purposes in the fields of oncology, blood disorders, neurological disorders, namely central nervous system disorders, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, muscular dystrophy, cerebral palsy, spina bifida, encephaly, myelopathy, migraines, ischemia, stroke, ataxia, sciatica, muscular sclerosis, neuropathic pain, central nervous system infections, neuromuscular disorders, neuroinflammatory disease, neural degeneration, brain injury, spinal cord injury and seizure disorders, genetic disorders, and immunology.

Classification kind code

Mark Details

Serial Number

2173333

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 23^rd Jun 2023	Search Recorded
Submitted for opposition 20 on 23^rd Jun 2023	Examiner's First Report
Submitted for opposition 223 on 23^rd Jun 2023	Total Provisional Refusal
Submitted for opposition 256 on 17^th Jan 2023	Notification of Possible Opposition Sent
Submitted for opposition 48 on 22^nd Jun 2022	Agent Changed
Submitted for opposition 257 on 17^th Mar 2022	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 16^th Mar 2022	Created
Submitted for opposition 31 on 16^th Mar 2022	Formalized
Submitted for opposition 30 on 31^st Jan 2022	Filed
Submitted for opposition 228 on 31^st Jan 2022	International Registration